Tioga Cardiovascular, A Shifamed Portfolio Company, Closes $30M In Series C Financing
Amount Raised
$30 Million
Round Type
Series C
CampbellManufacturingBiotechnologyHealth CareMedical DeviceInvestors
Description
Tioga Cardiovascular, a Shifamed portfolio company that aims to redefine structural heart valve replacement, announced today the first closing of its $30M Series C financing. Led by Cormorant Asset Management, with significant participation from The Capital Partnership, AMED Ventures, the PA MedTech VC Fund, and Shifamed angel investors, the financing will be used to continue product development, support pre-clinical testing, and initiate first-in-human use for the company's novel transseptal mitral valve replacement (TMVR) technology.
Quick answer
Tioga Cardiovascular raised $30 Million in a Series C round, dated February 9, 2023. Investors: Shifamed Angel Investors, The Capital Partnership, Amed Ventures, Pa Med Tech Vc Fund and Cormorant Asset Management. Tioga Cardiovascular is based in Campbell, California, United States.
- How much did Tioga Cardiovascular raise?
- Tioga Cardiovascular raised $30 Million in a Series C round on February 9, 2023.
- Who invested in Tioga Cardiovascular?
- Shifamed Angel Investors, The Capital Partnership, Amed Ventures, Pa Med Tech Vc Fund and Cormorant Asset Management are named as investors in this round.
- What does Tioga Cardiovascular do?
- Tioga Cardiovascular, a privately held portfolio company of Shifamed LLC, is focused on providing elegant valve replacement solutions for mitral and tricuspid applications that are procedurally simpler and use a less..
- Where is Tioga Cardiovascular based and how big is it?
- Tioga Cardiovascular is based in Campbell, California, United States. Fundz records about 21 employees.
Source: Fundz verified event record.
Who else raised in Medical Device and Manufacturing around the same time
Companies in the same sectors as Tioga Cardiovascular that raised within 45 days of this round, from Fundz verified event records.
- Flyte Aviation, Inc. raised $8M on March 23, 2023.
- Evergreen Theragnostics raised $15M (Series B) on March 13, 2023.
- NuVision Biotherapies raised $1.3M (Seed) on March 9, 2023.
- MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
- Cognito Therapeutics raised $73M (Series B) on March 23, 2023.
- Eximis Surgical raised $15M on March 21, 2023.
Who to call at Tioga Cardiovascular, and when
A new round usually means Tioga Cardiovascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tioga Cardiovascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tioga Cardiovascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tioga Cardiovascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tioga Cardiovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Tioga Cardiovascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.